Lamivudine Tablet, Film Coated
Product Images NDC 60429-354

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60429-354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 353 60lb Lamivudine 150 mg Tabs

Label for LAMIVUDINE 150 mg film-coated tablets with 60 tablets per bottle. The label shows the NDC number 60429-353-60 and includes storage instructions. It is labeled as prescription only (Rx only) and manufactured by Golden State Medical Supply, Inc.*

FDA Label Image

60429 354 30lb Lamivudine 300mg Tabs

Lamivudine 300 mg film-coated tablets in a bottle package containing 30 tablets, labeled by Golden State Medical Supply, Inc. The label includes the NDC 60429-354-30 and storage instructions. The product is marked as Rx only and includes warnings to keep medication out of reach of children and protect from moisture.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of lamivudine, showing its molecular arrangement including oxygen, nitrogen, sulfur atoms, and an amino group.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing proportions of patients with HIV-1 RNA below 400 copies/mL over time (in weeks) for Lamivudine 150 mg twice daily and 300 mg once daily dosages. The x-axis shows treatment time up to 48 weeks, and the y-axis represents proportions of patients achieving viral suppression. Both dosage groups show similar trends in viral suppression over the treatment period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.